Commissioning vs Qualification in Cannabis GMP

Article · 10 min read · Public

In this article Overview What commissioning is What qualification is The key differences Where they overlap The correct sequence Common mistakes Frequently asked questions Key takeaways

Why the distinction matters

Commissioning and qualification are related but distinct activities in the lifecycle of pharmaceutical equipment and facilities. Confusing them — or, more commonly, using commissioning activities as a substitute for qualification — is a consistent source of inspection findings in cannabis manufacturing facilities. Understanding the difference is foundational to building a credible validation programme.

The distinction is not merely semantic. From a regulatory perspective, EU GMP requires formal qualification of equipment, utilities and systems used in pharmaceutical manufacturing. Commissioning, however thorough, does not satisfy this requirement. A cannabis facility that has commissioned its equipment but not qualified it is not GMP-compliant, regardless of how well the equipment is performing in production.

What commissioning is

Commissioning is the process of verifying and documenting that a piece of equipment, utility or facility system has been installed and is functioning correctly in accordance with the manufacturer's specifications and the purchaser's requirements. It is an engineering process, primarily owned by the engineering or facilities function, and it is focused on confirming that the system works as built.

Commissioning typically involves:

Verifying that equipment has been installed in accordance with supplier drawings and specifications
Confirming that utilities — electrical supply, compressed air, water, HVAC connections — are correctly connected and within range
Running functional tests to confirm that the equipment operates as specified by the manufacturer
Identifying and resolving any snag items before handover to production
Generating a commissioning report documenting the activities performed and their outcomes

Commissioning is performed under engineering control. The documentation standards are engineering standards — thorough, but not necessarily structured to the pharmaceutical GMP documentation requirements that apply to qualification protocols and reports. Commissioning work may be performed by the equipment supplier, by in-house engineers, or by a specialist commissioning contractor.

For cannabis facilities constructed or upgraded to pharmaceutical standards, commissioning is typically performed as part of the project delivery process, before the facility is handed over to quality and production teams. It is a necessary precursor to qualification — qualification cannot begin until commissioning is complete and the equipment is in a known, functioning state — but it is not a substitute for qualification.

What qualification is

Qualification is the formal, documented process of demonstrating that equipment, utilities and systems perform consistently within defined parameters and are fit for their intended pharmaceutical purpose. It is a GMP activity, owned and approved by the quality function, and it must follow approved protocols with pre-defined acceptance criteria.

EU GMP requires qualification of equipment, premises and utilities as part of the validation framework. The requirement is explicit in EU GMP Part I Chapter 3 (Premises and Equipment) and is detailed in EU GMP Annex 15 (Qualification and Validation). ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients) also addresses qualification requirements for API manufacturers.

Qualification is structured into phases:

Design Qualification (DQ) — formal review and approval of the design of equipment or systems against user requirements and GMP standards, typically performed before procurement or construction. DQ confirms on paper that the design is fit for pharmaceutical purpose.
Installation Qualification (IQ) — documented verification that equipment has been installed in accordance with approved specifications, drawings and GMP requirements. IQ overlaps with commissioning in scope but must be performed under GMP control, with an approved protocol and formal report.
Operational Qualification (OQ) — documented evidence that equipment operates as intended across its operating range, under GMP-controlled conditions, with pre-defined acceptance criteria tested and met.
Performance Qualification (PQ) — documented evidence that equipment consistently produces results meeting specification under routine operating conditions, using actual production materials and processes.

The key differences

The fundamental difference between commissioning and qualification is one of ownership, control and purpose:

Ownership: Commissioning is owned by engineering. Qualification is owned by quality. Qualification protocols and reports must be approved by the quality function before execution begins and after completion.
Control: Commissioning follows engineering project management standards. Qualification follows GMP documentation standards — approved protocols, contemporaneous records, formal deviation reporting, signed reports with QA approval.
Purpose: Commissioning confirms the equipment works. Qualification demonstrates, through documented evidence, that the equipment performs consistently within defined limits and is fit for pharmaceutical manufacturing.
Regulatory standing: Commissioning documentation does not satisfy GMP qualification requirements. An inspector will not accept commissioning records as evidence of qualification. Separate, QA-approved qualification documentation is required.

Where they overlap — and how to use it efficiently

EU GMP Annex 15 acknowledges that commissioning activities generate useful technical data that can be leveraged in qualification. The concept of "enhanced commissioning" or "good engineering practice" (GEP) acknowledges that thorough commissioning work can reduce the scope of formal qualification testing — where commissioning has already demonstrated that a system is installed correctly and operates within range, the qualification can focus on the GMP-critical parameters rather than repeating all the same tests.

This approach — using commissioning data to support qualification, rather than repeating identical testing — is accepted by EU regulators provided that the commissioning work meets defined quality standards and the decision to leverage it is formally risk-assessed and documented. In practice, this means that commissioning documentation must meet minimum quality requirements (controlled documents, witnessed testing, accurate records) to be usable in the qualification programme.

For cannabis facilities, this is practically significant. Qualification is resource-intensive. Using well-executed commissioning data to reduce the qualification testing burden — where the risk assessment supports it — is a legitimate and accepted approach to managing the cost and timeline of building a GMP-compliant facility.

The correct sequence

The correct sequence for a new or significantly modified cannabis manufacturing system is:

User Requirements Specification (URS) — define what the system must do
Design Qualification (DQ) — confirm the design meets the URS and GMP requirements
Procurement and construction/installation
Factory Acceptance Testing (FAT) — supplier testing before delivery, can contribute to IQ data
Site Acceptance Testing (SAT) — on-site testing post-delivery, can contribute to IQ data
Commissioning — engineering confirmation that the system is installed and functioning
IQ — formal GMP documentation that installation meets approved specifications
OQ — formal testing that the system operates within defined parameters
PQ — formal testing that the system performs consistently in production

Qualification must not begin until commissioning is complete and any outstanding items (snag list) have been resolved. Starting qualification on incompletely commissioned equipment means the qualification may need to be repeated after commissioning issues are resolved — an inefficient and costly approach.

Common mistakes in cannabis operations

Using commissioning records as qualification evidence — the most common error. Commissioning records are useful input into qualification but cannot replace GMP-approved qualification protocols and reports.
Starting qualification before commissioning is complete — creates the risk that qualification failures result from commissioning issues rather than genuine performance limitations, wasting qualification resource.
Skipping DQ — Design Qualification is often considered optional, but it is the most cost-effective quality intervention in the process. Catching design issues on paper is significantly cheaper than catching them during IQ or OQ.
Inadequate acceptance criteria — OQ acceptance criteria defined after reviewing the test results are not valid. Criteria must be defined and approved before testing begins.
No requalification after significant changes — equipment modifications made under change control may require partial or full requalification. Many cannabis operations modify equipment informally without assessing the qualification impact.

Frequently asked questions

Can a cannabis facility use supplier commissioning data in its qualification?

Yes, provided the commissioning data meets minimum quality standards and the decision to use it is formally risk-assessed and documented. EU GMP Annex 15 supports the use of commissioning data where it meets defined quality requirements. The quality function must formally assess and approve the use of commissioning data in the qualification programme.

Is Design Qualification mandatory under EU GMP?

EU GMP Annex 15 states that the principles of qualification should be applied to all critical systems and equipment. DQ is described as a part of the qualification process, and its absence will be noted in an inspection. In practice, for new facilities or major equipment procurement, DQ is expected. For minor equipment or low-risk items, a risk-based approach may support a reduced qualification scope.

Does qualification need to be repeated after every maintenance activity?

Not after every maintenance activity, but after any change that could affect the qualified state of the equipment. The change control process should include an assessment of qualification impact for any modification to qualified equipment. Routine preventive maintenance that does not change the equipment configuration typically does not require requalification, though it must be performed according to approved procedures and documented.

Key takeaways

Commissioning and qualification are distinct processes serving different purposes. Commissioning confirms engineering functionality; qualification demonstrates GMP-compliant performance.
Qualification is owned and approved by quality. Commissioning is owned by engineering.
Commissioning must be completed before qualification begins.
Commissioning data can be leveraged in qualification, but only where it meets defined quality standards and the decision is formally documented.
The correct sequence is: URS → DQ → FAT/SAT → Commissioning → IQ → OQ → PQ.
Acceptance criteria must be defined before testing, not after reviewing results.

References

EU GMP Annex 15 — Qualification and Validation
EU GMP Part I Chapter 3 — Premises and Equipment
ICH Q7 — Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
ISPE Baseline Guide Volume 5 — Commissioning and Qualification (3rd Edition)

What to do next

The CCVP certification covers the full qualification lifecycle including commissioning interface, IQ/OQ/PQ protocol development and the risk-based approach to validation scope.

View CCVP Certification Start GMP Lite